Literature DB >> 24492068

Fibroblast-mediated pathways in cardiac hypertrophy.

Katsuhito Fujiu1, Ryozo Nagai2.   

Abstract

Under normal physiological conditions, cardiac fibroblasts are the primary producers of extracellular matrix and supply a mechanical scaffold for efficacious heart contractions induced by cardiomyocytes. In the hypertrophic heart, cardiac fibroblasts provide a pivotal contribution to cardiac remodeling. Many growth factors and extracellular matrix components secreted by cardiac fibroblasts induce and modify cardiomyocyte hypertrophy. Recent evidence revealed that cardiomyocyte-cardiac fibroblast communications are complex and multifactorial. Many growth factors and molecules contribute to cardiac hypertrophy via different roles that include induction of hypertrophy and the feedback hypertrophic response, fine-tuning of adaptive hypertrophy, limitation of left ventricular dilation, and modification of interstitial changes. This review focuses on recent work and topics and provides a mechanistic insight into cardiomyocyte-cardiac fibroblast communication in cardiac hypertrophy. This article is part of a Special Issue entitled "Myocyte-Fibroblast Signalling in Myocardium ".
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac fibroblast; Cardiac hypertrophy; Fibroblast growth factor signaling; Notch signaling; S100A4; Thrombospondin-1 signaling

Mesh:

Substances:

Year:  2014        PMID: 24492068     DOI: 10.1016/j.yjmcc.2014.01.013

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  37 in total

1.  Cardiac Tissue Chips (CTCs) for Modeling Cardiovascular Disease.

Authors:  Aaron J Rogers; Jessica M Miller; Ramaswamy Kannappan; Palaniappan Sethu
Journal:  IEEE Trans Biomed Eng       Date:  2019-03-18       Impact factor: 4.538

2.  ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart.

Authors:  Yufeng Yao; Changqing Hu; Qixue Song; Yong Li; Xingwen Da; Yubin Yu; Hui Li; Ian M Clark; Qiuyun Chen; Qing K Wang
Journal:  Cardiovasc Res       Date:  2020-04-01       Impact factor: 10.787

3.  S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone.

Authors:  Ana Paula Cremasco Takano; Carolina Demarchi Munhoz; Anselmo Sigari Moriscot; Sudhiranjan Gupta; Maria Luiza Morais Barreto-Chaves
Journal:  J Mol Med (Berl)       Date:  2017-02-04       Impact factor: 4.599

Review 4.  Implication of sphingosin-1-phosphate in cardiovascular regulation.

Authors:  Ningjun Li; Fan Zhang
Journal:  Front Biosci (Landmark Ed)       Date:  2016-06-01

5.  Ets-1 upregulation mediates angiotensin II-related cardiac fibrosis.

Authors:  Guanghua Hao; Zhenhua Han; Zhe Meng; Jin Wei; Dengfeng Gao; Hong Zhang; Nanping Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 6.  Extracellular matrix-mediated cellular communication in the heart.

Authors:  Iñigo Valiente-Alandi; Allison E Schafer; Burns C Blaxall
Journal:  J Mol Cell Cardiol       Date:  2016-01-14       Impact factor: 5.000

7.  Myofibroblast β2 adrenergic signaling amplifies cardiac hypertrophy in mice.

Authors:  Atsuki Imaeda; Shota Tanaka; Kota Tonegawa; Shota Fuchigami; Masanori Obana; Makiko Maeda; Miho Kihara; Hiroshi Kiyonari; Simon J Conway; Yasushi Fujio; Hiroyuki Nakayama
Journal:  Biochem Biophys Res Commun       Date:  2019-01-23       Impact factor: 3.575

8.  Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction.

Authors:  Toru Shimizu; Nikhil Narang; Phetcharat Chen; Brian Yu; Maura Knapp; Jyothi Janardanan; John Blair; James K Liao
Journal:  JCI Insight       Date:  2017-07-06

9.  Syndecan-4 Signaling Is Required for Exercise-Induced Cardiac Hypertrophy.

Authors:  Jun Xie; Guixin He; Qinhua Chen; Jiayin Sun; Qin Dai; Jianrong Lu; Guannan Li; Han Wu; Ran Li; Jianzhou Chen; Wei Xu; Biao Xu
Journal:  Mol Med       Date:  2016-01-21       Impact factor: 6.354

Review 10.  Redefining the identity of cardiac fibroblasts.

Authors:  Michelle D Tallquist; Jeffery D Molkentin
Journal:  Nat Rev Cardiol       Date:  2017-04-24       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.